Log In
Print
BCIQ
Print
Print this Print this
 

MBX-2982, SAR26009

  Manage Alerts
Collapse Summary General Information
Company CymaBay Therapeutics Inc.
DescriptionG protein-coupled receptor 119 (GPR119) agonist
Molecular Target G protein-coupled receptor 119 (GPR119)
Mechanism of ActionG protein-coupled receptor 119 (GPR119) agonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$375.0M

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today